DMC Group LLC Buys Shares of 542 Intuitive Surgical, Inc. (NASDAQ:ISRG)

DMC Group LLC purchased a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 542 shares of the medical equipment provider’s stock, valued at approximately $283,000.

Several other institutional investors and hedge funds have also recently modified their holdings of ISRG. Legacy Trust lifted its stake in Intuitive Surgical by 3.0% in the fourth quarter. Legacy Trust now owns 12,142 shares of the medical equipment provider’s stock worth $6,338,000 after acquiring an additional 356 shares during the period. Strategic Planning Group LLC increased its position in shares of Intuitive Surgical by 2.6% during the fourth quarter. Strategic Planning Group LLC now owns 13,199 shares of the medical equipment provider’s stock worth $6,890,000 after purchasing an additional 333 shares in the last quarter. Highland Capital Management LLC raised its stake in Intuitive Surgical by 0.8% in the fourth quarter. Highland Capital Management LLC now owns 6,319 shares of the medical equipment provider’s stock valued at $3,298,000 after buying an additional 51 shares during the last quarter. Baader Bank Aktiengesellschaft boosted its stake in Intuitive Surgical by 105.8% in the 4th quarter. Baader Bank Aktiengesellschaft now owns 2,224 shares of the medical equipment provider’s stock worth $1,161,000 after purchasing an additional 40,290 shares in the last quarter. Finally, Hanson & Doremus Investment Management acquired a new position in shares of Intuitive Surgical in the 4th quarter valued at $230,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $572.71 on Thursday. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00. The firm’s 50-day moving average is $548.70 and its two-hundred day moving average is $507.04. The firm has a market capitalization of $203.99 billion, a PE ratio of 92.08, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on ISRG shares. Citigroup raised their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. The Goldman Sachs Group set a $604.00 target price on shares of Intuitive Surgical in a research note on Friday, October 18th. Bernstein Bank boosted their price target on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research report on Monday. Finally, BTIG Research raised their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research note on Tuesday, November 26th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Insiders Place Their Bets

In related news, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total transaction of $202,664.00. Following the sale, the executive vice president now directly owns 5,506 shares in the company, valued at $2,967,734. This trade represents a 6.39 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Jamie Samath sold 94 shares of the business’s stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the sale, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at $1,502,019.30. The trade was a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 28,843 shares of company stock worth $15,357,560 over the last 90 days. Corporate insiders own 0.90% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.